Journal of Clinical Sleep Medicine, Vol. 4, No. 5, 2008
503
35. ErmanM,SeidenD,ZammitG,SainatiS,ZhangJ.Anefcacy,
safety, and dose-response study of Ramelteon in patients with
chronicprimaryinsomnia.SleepMed2006;7:17-24.
36. RothT,StubbsC,WalshJK,etal.Ramelteon(TAK-375),ase-
lectiveMT1/MT2-receptoragonist,reduceslatencytopersistent
sleep in a model of transient insomnia related to a novel sleep
environment.Sleep2005;28:303-7.
37. BarberaJ,ShapiroC.Benet-riskassessmentofzaleploninthe
treatmentofinsomnia.DrugSaf2005;28:301-18.
38. HajakG,RodenbeckA,VoderholzerU,etal.Doxepininthetreat-
ment of primary insomnia: a placebo-controlled, double-blind,
polysomnographicstudy.JClinPsychiatry2001;62:453-63.
39. RiemannD,Voderholzer,U,CohrsS,etal.Trimipramineinpri-
maryinsomnia:resultsofapolysomnographicdouble-blindcon-
trolledstudy.Pharmacopsychiatry2002;35:165-74.
40. MendelsonW.Areviewoftheevidencefortheefcacyandsafe-
tyoftrazodoneininsomnia.JClinPsychiatry2005;66:469-76.
41. WalshJ,ErmanM,ErwinCW,etal.Subjectivehypnoticefcacy
oftrazodoneandzolpideminDSMIII-Rprimaryinsomnia.Hum
Psychopharmacol1998;13:191-8.
42. WinokurA,DeMartinisNA3rd,McNallyDP,GaryEM,Cormier
JL,GaryKA.Comparativeeffectsofmirtazapineanduoxetine
on sleep physiology measures with major depression and insom-
nia.JClinPsychiatry2003;64:1224-9.
43. Morin CM, Koetter U, Bastien C, Ware JC, Wooten V. Vale-
rian-hops combination and diphenhydramine for treating in-
somnia: a randomized placebo-controlled clinical trial. Sleep
2005;28:1465-71.
44. BentS,PadulaA,MooreD,etal.Valerianforsleep:asystematic
reviewandmeta-analysis.AmJMed2006;119:1005-12.
45. Brzezinski A, Vangel MG, Wurtman RJ, et al. Effects of ex-
ogenous melatonin on sleep: a meta-analysis. Sleep Med Rev
2005;6:41-50.
46. Buscemi N, Vandermeer B, Hooton N, et al. The efcacy and
safety of exogenous melatonin for primary sleep disorders: a
meta-analysis.JGenInternMed2005;20:1151-8.
47. WheatleyD.Kavaandvalerianinthetreatmentofstress-induced
insomnia.PhytotherRes2001;15:549-51.
48. MeoliA,RosenC,KristoD,etal.Oralnonprescriptiontreatment
forinsomnia:anevaluationofproductswithlimitedevidence.J
ClinSleepMed2005;1:173-87.
49. PerlisML,McCallWV,KrystalAD,WalshJK.Long-term,non-
nightly administration of zolpidem in the treatment of patients
withprimaryinsomnia.JClinPsychiatry2004;65:1128-37.
50. HajakG,Cluydts R,DeclerckA,etal.Continuousversusnon-
nightlyuseofzolpideminchronicinsomnia:resultsofalarge-
scale,double-blind, randomized,outpatient study.Int ClinPsy-
chopharmacol2002;17:9-17.
51. WalshJ,RothT,RandazzoA,etal.Eightweeksofnon-nightly
useofzolpidemforprimaryinsomnia.Sleep2000;28:1087-96.
52. KrystalA,WalshJK,LaskaEetal.Sustainedefcacyofeszopi-
cloneover6monthsofnightlytreatment:resultsofarandomized,
double-blind, placebo-controlled study in adults with chronic in-
somnia.Sleep2003;26:793-9.
53. RothT,WalshJK,KrystalA,WesselT,RoehrsTA.Anevaluation
oftheefcacyandsafetyofeszopicloneover12monthsinpa-
tientswithchronicprimaryinsomnia.SleepMed2005;6:487-95.
54. Ancoli-IsraelS,RichardsonGS,ManganoRM,JenkinsL,HallP,
JonesWS.Long-termuseofsedativehypnoticsinolderpatients
withinsomnia.SleepMed2005;6:107-13.
55. OhayonM,CauletM,ArbusL,etal.Areprescribedmedications
effectiveinthetreatmentofinsomniacomplaints?JPsychosom
Res1999;47:359-68.
56. MerlottiL,RoehrsT,ZorickF,RothT.Reboundinsomnia:dura-
tionof use and individual differences.J Clin Psychopharmacol
1991;11:368-73.
11. TaylorD,MalloryLJ,LichsteinKL,etal.Comorbidityofchronic
insomniawithmedicalproblems.Sleep2007;30:213-8.
12. Benca R,Ancoli-IsraelS, MoldofskyH. Special considerations
ininsomniadiagnosisandmanagement:depressed,elderly,and
chronicpainpopulations.JClinPsychiatry2004;65:S26-S35.
13. OhayonM.Epidemiologyofinsomnia:whatweknowandwhat
westillneedtolearn.SleepMedRev2002;6:97-111.
14. MorinC,LeBlancM,DaleyM,GregoireJP,MeretteC.Epide-
miology of insomnia: prevalence, self-help treatments, consul-
tations,anddeterminantsofhelp-seekingbehaviors.SleepMed
2006;7:123-30.
15. PerlisM,SmithMT,PigeonWR.Etiologyandpathophysiology
ofinsomnia.In:KrygerMH,RothT,DementWC,eds.Principles
and practice of sleep medicine, 4th ed. Philadelphia: Elsevier
Saunders,2005:714-25.
16. Perlis M, Giles DE, Mendelson WB, Bootzin RR, Wyatt JK.
Psychophysiologicalinsomnia:thebehaviouralmodelandaneu-
rocognitiveperspective.JSleepRes1997;6:179-88.
17. SpielmanA,CarusoL,GlovinskyP.Abehavioralperspectiveon
insomniatreatment.PsychiatrClinicNorthAm1987;10:541-53.
18. Harvey A. A cognitive model of insomnia. Behav Res Ther
2002;40:869-93.
19. LichsteinK,DurrenceHH,TaylorDJ,etal.Quantitativecriteria
forinsomnia.BehavResTher2003;41:427-45.
20. EdingerJ,BonnetMH,BootzinRR,etal.Derivationofresearch
diagnosticcriteriaforinsomnia:ReportofanAmericanAcademy
ofSleepMedicineWorkGroup.Sleep2004;27:1567-96.
21. Sateia M, Doghramji K, Hauri PJ, et al. Evaluation of chronic
insomnia.Sleep2000;23:243-308.
22. SpielmanA,YangCM,GlovinskyPG.Assessmenttechniquesfor
insomnia.In:KrygerMH,RothT,DementWC,eds.Principles
and practice of sleep medicine, 4th ed. Philadelphia: Elsevier
Saunders,2005.
23. ToddArnedtJ,ConroyD,AloiaM.Evaluationofinsomniapa-
tients.SleepMedClin2006;1:319-32.
24. Hauri PJ. Consulting about insomnia: a method and some pre-
liminarydata.Sleep1993;16:344-50.
25. Leger D, Guilleminault C, Bader G, Levy E, Paillard, M.
Medical and socio-professional impact of insomnia. Sleep
2002;25:625-9.
26. Léger D, Massuel MA, Metlaine A; SISYPHE Study Group.
Professional correlates of insomnia [see comment]. Sleep
2006;29:171-8.
27. TaylorD,LichsteinKL,DurrenceHH.Insomniaasahealthrisk
factor.BehavSleepMed2003;1:227-47.
28. NationalInstitutesofHealth.NationalInstitutesofHealthState
oftheScienceConferencestatementonManifestationsandMan-
agementofChronicInsomniainAdults,June13-15,2005.Sleep
2005;28:1049-57.
29. LichsteinKL,WilsonNM,JohnsonCT.Psychologicaltreatment
ofsecondaryinsomnia.PsycholAging2000;15:232-40.
30. AmericanAcademyofSleepMedicine.Certiedbehavioralsleep
medicine specialists. http://www.aasmnet.org/BSMSpecialists.
aspx.2007.
31. AmericanAcademyofSleepMedicine.CentersforSleepMedi-
cine.http://www.sleepcenters.org/.2007.
32. HolbrookAM, CrowtherR,LotterA, ChengC,KingD. Meta-
analysis of benzodiazepine use in the treatment of insomnia.
CMAJ2000;162:225-33.
33. HolbrookA,CrowtherR,LotterA,EndeshawY.Theroleofben-
zodiazepinesinthetreatmentofinsomnia:meta-analysisofben-
zodiazepineuseinthetreatmentofinsomnia.JAmGeriatrSoc
2001;49:824-6.
34. NowellP, MazumdarS,BuysseDJ,etal. Benzodiazepinesand
zolpidemforchronicinsomnia:Ameta-analysisoftreatmentef-
cacy.JAMA1997;278:2170-7.
Evaluation and Management of Chronic Insomnia in Adults